1 / 20

Prenatal Diagnosis of Congenital Malformations

Prenatal Diagnosis of Congenital Malformations. Max Brinsmead PhD FRANZCOG January 2010. 3 categories of congenital disorder. Some 1- 2% of babies will have a major disability that dates from the prenatal period Either Chromosomal disorder e.g. Down syndrome

devon
Télécharger la présentation

Prenatal Diagnosis of Congenital Malformations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Prenatal Diagnosis of Congenital Malformations Max Brinsmead PhD FRANZCOG January 2010

  2. 3 categories of congenital disorder • Some 1- 2% of babies will have a major disability that dates from the prenatal period • Either • Chromosomal disorder e.g. Down syndrome • Structural abnormality e.g. “Hole in the Heart” • Other e.g. Cerebral palsy • While a good deal of antenatal care in the 21st century is directed to the prenatal detection of these problems.... • It is worth remembering that, for most, termination of the pregnancy is the only option

  3. What can be detected in utero? • All chromosomal abnormalities • About half of the major structural abnormalities • May be difficult in the 1st half of pregnancy • And varies with the resources available • Very few of the patients with cerebral palsy

  4. Types of Tests • Diagnostic tests • Have a high degree of accuracy • e.g. Amniocentesis for chromosomes • May be invasive, carry risk and expensive • Screening tests • Cheap and safe tests suitable for whole population • Selects a subgroup for diagnostic testing • So sensitivity and positive predictive value is important • Ultrasound can be used for both screening and diagnosis • Limited only by the resources available

  5. Two Practical Characteristics of a Screening Test • Sensitivity • The number of patients selected by the test as positive as a proportion of the total number of patients with the condition sought • e.g. A DRA test that identifies 3 out of 4 mothers with a Down syndrome baby has a sensitivity of 75% and will therefore miss 25% of the babies with this problem • Positive Predictive Value (PPV) • The likelihood that a patient identified by the test has the condition sought • e.g. A DRA with PPV of 10% means that 90% of women selected to undergo amniocentesis will NOT have this condition

  6. Markers for Down Syndrome • Ultrasound • Nuchal translucency (NT) ↑with DS • Nasal bone (absent with DS) • Maternal Serum • PAPP-A ↓with DS • Beta HCG ↑with DS • AFP ↓with DS and ↑with NTDs • Oestriol ↓with DS • Inhibin-A (useful in 2nd trimester testing)

  7. Down Syndrome screening tests • Use the combined test (i.e NT measure, beta-HCG & PAPP-A )for patients who present in the first trimester • Sensitivity when optimally timed is 85-88% • Can help many patients avoid amnio & CVS • Use the Triple Test (i.e. beta-HCG, E3 and AFP) for patients who present in the 2nd trimester • Sensitivity when optimally timed is 65 – 75% • Also screens for NTDs • Integrated testing offers greater sensitivity and higher PPV but results are late

  8. Information required for the interpretation of tests • Gestational age with accuracy • And this is why ultrasound c NT is so useful • Maternal age • Advancing age will increase the chance of a +ve result • Maternal ethnicity and weight • Multiple pregnancy? • Assisted conception? • Maternal diabetes? • Maternal smoking?

  9. Timing is all important • Firstly it is desirable to make a diagnosis before 14w so that TOP is simple and safe • 1st blood test between 9 – 13w&6d • Optimally 10 -12 w • NT measure at 11 – 13w&6d • Optimally at 11.5 – 13.5w • Second trimester blood test 14 – 20w • Optimally 14 – 18w • CVS can be performed any time after 9.5w • Amniocentesis after 15w

  10. Timing is all important • Full chromosomal analysis from CVS or amnio takes 10 – 14d • Culture failure occurs in <0.5% • Colony mosaicism can be a problem • Some abnormalities can pose dilemmas • e.g. 47 XYY, 47XXY, 45XO • Fast FISH or DNA tests can be done overnight • But are much more expensive • And have a small risk of error

  11. Some myths surrounding PND • Most Down Syndrome babies are born to women over the age of 35 • Because my other pregnancies and babies were normal I do not need testing • There is no Family History of Downs so I do not need testing • Husband’s age is important • The chance of aneuploidy after a positive screen test is equivalent to the risk calculated

  12. Amniocentesis and CVS • Practitioners of both state that the increased loss associated with both is about 1:100 • Large studies say 0.5% for amnio and 1-2% for CVS • Most pregnancy losses occur within 7 – 10d • A few patients leak liquor after amnio • CVS is done PA for an anterior placenta and PV for a posterior placenta • Both procedures require US guidance • And are best done by practitioners of >50/yr

  13. Issues a patient needs to understand before undergoing a test • What the test is for • And what it will not detect • What is their risk of the condition • What is the likelihood that the test will be positive • What are the sensitivity and PPV of the test • What will they do if the test is positive • What are the risks associated with further testing. What will that test reveal • What will they do if their baby is affected

  14. So Patient Counselling is Important • Pre test counselling will help to reduce post positive test anxiety • Resources are required for the optimal management of screen-positive patients • And the continuing care of patients who are screen-positive but amnio/CVS normal • Because they do have pregnancies at increased risk • Consultation with a MFM specialist may be desirable

  15. Increased Nuchal Translucency • When aneuploidy has been excluded... • Risk of miscarriage <20w is 1.3% for NT 95 – 99th centile • But is 20% when NT >6.5 mm • Look for cardiac abnormalities • 1.7% if NT is 2.5 – 3.4 mm • 7.5% if NT >3.5 mm • Is it Cystic Hygroma? i.e. generalised oedema • 5-fold increased risk of aneuploidy • 12-fold increased risk of cardiac problem • 6-fold increased risk of perinatal death • So monitor – consult MFM if it does not resolve

  16. Low PAPP-A • When beta-HCG is high exclude Downs • (Trisomy 13 & 18 associated with low beta HCG) • When aneuploidy is excluded.... • Monitor for early onset pre eclampsia & IUGR • ? Consult with MFM especially if beta HCG is high • Unexplained elevation of PAPP-A • “Not associated with any known pregnancy problem”

  17. Raised AFP • Causes include: • Wrong dates • Pregnancy bleeding • Multiple pregnancy • Open neural tube defects* • Anterior abdominal wall defects • Some rare tumours • So refer for tertiary level scanning • and • “Watch carefully” for the rest of the pregnancy

  18. Low oestriol in the 2nd Trimester • Think about: • Placental sulfatase deficiency • X-linked recessive • Ichthyosis (lizard-like skin) • Mild corneal opacification • Cryptorchidism • Smith Lemli-Opitz Syndrome (rare 1:50,000) • Multiple malformtions • Mental retardation • Syndactly • So consider amniocentesis or CVS

More Related